Opposite effects of calcitriol and paricalcitol on the PTH-(1-84)/ C-large fragment ratio in patients on hemodialysis.

被引：0
作者：
Faugere, MCM [1 ]
Mawad, HW [1 ]
Trueba, DM [1 ]
Friedler, RM [1 ]
Malluche, HH [1 ]
机构：
[1] Univ Kentucky, Div Nephrol Bone & Mineral Metab, Lexington, KY USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2003年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：686A / 686A
页数：1
相关论文
共 44 条
  • [21] PTH(1-84) and N-truncated PTH fragment in the serum and parathyroid glands of patients with primary hyperparathyroidism.
    Cohen, A
    LoGerfo, P
    Gao, P
    Brown, IB
    Trokan, S
    Cantor, T
    Bilezikian, JP
    Silverberg, J
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S156 - S156
  • [22] INCREASED ACTIVE PTH(1-84) FRACTION AS A PREDICTOR OF POOR MORTALITY IN MALE HEMODIALYSIS PATIENTS
    Hamamoto, Kae
    Inaba, Masaaki
    Okuno, Senji
    Imanishi, Yasuo
    Ishimura, Eiji
    Yamakawa, Tomoyuki
    Shoji, Shigeichi
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 263 - 263
  • [23] Calcium dependant changes in PTH 1-84 and amino-terminally truncated PTH fragment in patients with ESRD.
    Salusky, IB
    Kuizon, BD
    Lavigne, J
    Zahradnik, RJ
    Jueppner, H
    Goodman, WG
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 194A - 195A
  • [24] Results of 36,047 patient values for intact PTH, 1-84 PTH (CAP), C terminal PTH fragments (7-84 PTH) and ratio.
    Cantor, T
    Glowacki, P
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 901A - 901A
  • [25] Serum estradiol but not 1-84 PTH is a significant contributor to BMD at second metacarpal bone in hemodialysis patients
    Mikami, Satoshi
    Hamano, Takayuki
    Tomida, Koudou
    Katayama, Masaya
    Ito, Takahito
    Imai, Enyu
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 : 179 - 180
  • [26] 1-84 parathyroid hormone (PTH)/PTH fragment ratio changes after percutaneous ethanol injection to parathyroid gland (PEIT) in secondary hyperparathyroidism of dialysis patients.
    Kimata, N
    Akiba, T
    Kikuchi, T
    Nitta, K
    Miwa, N
    Kawashima, A
    Higuchi, R
    Yamashita, N
    Nihei, H
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 587A - 587A
  • [27] Positive correlation of serum bio-intact PTH(1-84) but not intact PTH with parathyroid gland size in hemodialysis patients
    Inaba, M
    Okuno, S
    Chou, H
    Imanishi, Y
    Ueda, M
    Yamakawa, T
    Ishimura, E
    Nishizawa, Y
    BIOMEDICINE & PHARMACOTHERAPY, 2006, 60 (02) : 62 - 65
  • [28] An evaluation of 1-84 PTH measurement in relation to bone alkaline phosphatase and bone Gla protein in hemodialysis patients
    Miwa, N
    Nitta, K
    Kimata, N
    Watanabe, Y
    Suzuki, K
    Kawashima, A
    Haga, M
    Watanabe, R
    Aoki, T
    Akiba, T
    Nihei, H
    NEPHRON CLINICAL PRACTICE, 2003, 94 (02): : C29 - C32
  • [29] Is (1-84) PTH assay better than intact PTH assay as an indicator of the bone turnover condition in patients under maintenance hemodialysis?
    Kawahara, K
    Minakuchi, J
    Kawashima, S
    Tsukaguchi, H
    Doi, T
    Matsumoto, T
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 782A - 782A
  • [30] Concurrent evaluation of PTH in hemodialysis patients using N-tact-IRMA and third generation Liaison 1-84 PTH (DiaSorin)
    Benchetrit, Sydney
    Green, Janice
    Bernheim, Jacques
    Golan, Eliezer
    Zitman-Gal, Tali
    CLINICAL BIOCHEMISTRY, 2013, 46 (4-5) : 395 - 396
12345